Pembrolizumab: Solution concentrate for I.V. infusion 100 mg in 4 mL; Keytruda® Page last updated: 2 July 2021 Public Summary Document (PSD) March 2021 PBAC Meeting - (PDF 1818KB) Public Summary Document (PSD) March 2021 PBAC Meeting - (Word 674KB)